Table 1.
Biological activity | Targets | Possible application in diseases |
---|---|---|
Cardiovascular effect | ||
Vasorelaxation | Ca2+ Endothelin-1 |
Coronary artery disease Acute ischemic stroke Chronic renal failure |
Cerebrovascular effect | ||
Neuroprotection | ACHE* BuCHE* |
Alzheimer’s disease |
Antibacterial activity | Superoxide radicals | G+ & G− bacterial infection |
Anti-inflammatory activity | NF-κB, COX-1, IL-1, IL-2 TLR4*, TAK1* |
Inflammation |
Antioxidant activity | Superoxide radicals SOD, CAT, GPx |
Aging; Cancer; Obesity Alzheimer’s disease |
Antidiabetes | AMPK, PPARγ | Diabete; Obesity Hyperlipidemia |
Anti-fibrosis | MMPs, JNK | Liver, lung, heart, kidney fibrosis |
Anticancer | Detailedly discussed below |
ACHE: Acetylcholinesterase; BuCHE: Butyrylcholinesterase; TLR4: Toll-like receptor 4; TAK1: TGF-β-activated kinase 1;